Drug Development Solutions

1. Patient-Centric Solutions: Taste Masking 6/14/2021

   Taste, smell, and mouthfeel are the key product features to address when developing pediatric formulations. Incremental formulation and clinical research require cost-effective solutions with flexibility in manufacturing scale.

2. ADC Payload-Linker Services 9/23/2025

   Explore how advanced high-potency capabilities and specialized expertise are driving the development and manufacturing of next-generation ADC payloads and linkers.

3. Immunogenicity Testing Evolved 5/20/2024

   The success of protein-based drugs hinges on identifying potential immune system reactions early in development. Learn about an immunogenicity testing technology that offers unparalleled sensitivity.

4. Develop. De-risk. Deliver. 6/10/2021

   Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.

5. Integrated Programs To Bridge Molecules From Discovery Into Clinical Development 1/4/2023

   A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.

6. PBPK Predictive Modeling Services

   Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

7. UpTempo℠ AAV Platform Process

   Catalent’s UpTempo℠ AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.

8. Advanced Linker Payload Solutions 7/11/2024

   Our expertise with mAbs and linker technologies ensures the development of ADCs that are not only effective and safe but also tailored to address the specific challenges of targeted therapies.

9. Engineering Antibodies And Proteins 6/28/2024

   Accurate protein engineering has become an essential step in the early discovery phase, minimizing the need for costly redesigns and process optimizations later in development.

10. HyClone Cell Boost 3 Supplement 9/21/2020

    Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 3 Supplement provides nutrients such as amino acids, glucose, and trace elements that are suitable for research and bioprocessing applications.